We are live on ! Find out more
AI

Analytic Investors Portfolio holdings

AUM $8.93B
1-Year Est. Return 13.54%
This Fund
S&P 500
This Quarter Est. Return
-1.9%
1 Year Est. Return
+13.54%
3 Year Est. Return
+42.14%
5 Year Est. Return
10 Year Est. Return
AUM
$7.48B
AUM Growth
+$359M
Cap. Flow
+$584M
Cap. Flow %
7.8%
Top 10 Hldgs %
21.43%
Holding
699
New
142
Increased
200
Reduced
165
Closed
156

Top Buys

Rank Stock Value
1
MKC icon
McCormick & Company Non-Voting
MKC
+$89.6M
2
SYY icon
Sysco
SYY
+$82.3M
3
CAH icon
Cardinal Health
CAH
+$72M
4
LMT icon
Lockheed Martin
LMT
+$70M
5
T icon
AT&T
T
+$47.1M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$91.5M
2
PRE
PARTNERRE LTD
PRE
+$65.4M
3
ETR icon
Entergy
ETR
+$54.8M
4
IBM icon
IBM
IBM
+$48.2M
5
LLY icon
Eli Lilly
LLY
+$36.7M

Sector Composition

Rank Sector Weight
1 Consumer Staples 30.79%
2 Healthcare 14.4%
3 Financials 12.33%
4 Consumer Discretionary 7.88%
5 Industrials 7.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DGICA icon
526
Donegal Group Class A
DGICA
$714M
$206K ﹤0.01%
14,687
EDE
527
DELISTED
Empire District Electric
EDE
$204K ﹤0.01%
9,257
UCFC
528
DELISTED
United Community Financial Corp
UCFC
$198K ﹤0.01%
39,663
+1,807
+5% +$9.19K
RITM icon
529
Rithm Capital
RITM
$5.42B
$194K ﹤0.01%
14,799
FLG
530
Flagstar Bank National Association
FLG
$5.74B
$194K ﹤0.01%
+3,573
New +$194K
AROC icon
531
Archrock
AROC
$6.12B
$186K ﹤0.01%
+10,311
New +$247K
MTSN
532
DELISTED
MATTSON TECHNOLOGY INC
MTSN
$150K ﹤0.01%
+64,255
New +$182K
RDI icon
533
Reading International Class A
RDI
$33.4M
$135K ﹤0.01%
10,673
MACK
534
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$134K ﹤0.01%
+2,005
New +$164K
CWEN.A
535
DELISTED
Clearway Energy Class A
CWEN.A
$117K ﹤0.01%
+10,512
New +$180K
ELNK
536
DELISTED
EarthLink Holdings Corp.
ELNK
$110K ﹤0.01%
14,185
-907
-6% -$7.4K
SRNE
537
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$96K ﹤0.01%
+11,422
New +$182K
IOVA icon
538
Iovance Biotherapeutics
IOVA
$2.15B
$71K ﹤0.01%
+12,313
New +$95.9K
CORT icon
539
Corcept Therapeutics
CORT
$9.95B
$54K ﹤0.01%
+14,445
New +$73.3K
FBP icon
540
First Bancorp
FBP
$4.44B
$43K ﹤0.01%
12,053
-1,431
-11% -$5.8K
ACIC icon
541
American Coastal Insurance
ACIC
$523M
-79,174
Closed -$1.23M
ADM icon
542
Archer Daniels Midland
ADM
$39.8B
-99,602
Closed -$4.8M
AHT
543
Ashford Hospitality Trust
AHT
$20.9M
-10
Closed -$85K
ALLY icon
544
Ally Financial
ALLY
$13.4B
-376,243
Closed -$8.44M
ALNY icon
545
Alnylam Pharmaceuticals
ALNY
$38.4B
-6,142
Closed -$736K
AMBA icon
546
Ambarella
AMBA
$2.98B
-6,888
Closed -$707K
AMP icon
547
Ameriprise Financial
AMP
$48.6B
-76,085
Closed -$9.51M
AN icon
548
AutoNation
AN
$7.26B
-3,592
Closed -$226K
ANIK icon
549
Anika Therapeutics
ANIK
$203M
-10,156
Closed -$335K
ASPS icon
550
Altisource Portfolio Solutions
ASPS
$61M
-1,315
Closed -$324K

Similar funds

Analytic Investors's Q3 2015 Portfolio in Review

As of Q3 2015, Analytic Investors held 699 positions worth $7.48B, up 5% from $7.12B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Analytic Investors deployed $584M of net new capital in Q3 2015, opening 142 new positions and adding to 200 existing holdings. Its largest new stake was Sysco: 2,156,702 shares worth $84M.

By sector, the portfolio is most concentrated in Consumer Staples at 31% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Merck, an estimated $91.5M trimmed.

  • Analytic Investors's largest Q3 2015 buy was Sysco: 2,156,702 shares worth $84M.
  • Analytic Investors added most to McCormick & Company Non-Voting in Q3 2015, an estimated $89.6M increase.
  • Analytic Investors's biggest Q3 2015 reduction was Merck, cutting an estimated $91.5M.
  • Analytic Investors fully exited OMNICARE INC in Q3 2015, selling an estimated $31.3M.
  • Analytic Investors's ten largest holdings make up 21% of its $7.48B portfolio in Q3 2015.
  • Analytic Investors opened 142 new positions and closed 156 in Q3 2015.
  • Analytic Investors's portfolio value rose 5% quarter-over-quarter to $7.48B.

Based on Analytic Investors's 13F filing for Q3 2015, filed 12 Nov 2015.